SCHEMBL13231701

SCHEMBL13231701

CC1(C)c2ccccc2N(c2cc(N3c4ccccc4C(C)(C)c4ccccc43)nc(-c3ccccc3)n2)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.42
▸ LMNA P02545 5/20 0.39
▸ MAPT P10636 5/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22309913 0.87 HPGD (0.40) HTTLMNAMAPTHSP90AA1GAA
SCHEMBL15490803 0.84 L3MBTL1 (0.44) HTTLMNAMAPTHSP90AA1GAA
SCHEMBL17739621 0.84 L3MBTL1 (0.40) HTTLMNAMAPTHSP90AA1GAA
SCHEMBL17206568 0.83 HPGD (0.40) HTTLMNAMAPTTSHRMAPK1
SCHEMBL15394839 0.82 KMT2A (0.37) HTTLMNAMAPTGAATSHR
SCHEMBL18624231 0.82 L3MBTL1 (0.40) LMNAMAPTHSP90AA1GAATSHR
SCHEMBL13231651 0.82 L3MBTL1 (0.40) HTTLMNAMAPTHSP90AA1GAA
SCHEMBL18624228 0.82 L3MBTL1 (0.40) LMNAMAPTHSP90AA1GAATSHR
SCHEMBL17206578 0.82 HPGD (0.41) LMNAMAPTHSP90AA1GAATSHR
SCHEMBL17278591 0.81 L3MBTL1 (0.42) LMNAMAPTTSHRMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100171417-A1 CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-07-08 — — US disclosed
US-20100171417-A1 CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100171417-A1 CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, SLC67A1, SLC26A3 HTT 1728/4885LMNA 1013/4885MAPT 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback